Ye JM, et al. Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance. Am. J. Physiol. Endocrinol. Metab. Apr 2001; 280(4): E562-E569.
Kaygisiz Z, et al. The effect of adrenomedullin, amylin fragment 8-37 and calcitonin gene-related peptide on contractile force, heart rate and coronary perfusion pressure in isolated rat hearts. Acta Physiol Hung. 2003; 90(2): 133-146.
Arsenijevic D, et al. Enterostatin decreases postprandial pancreatic UCP2 mRNA levels and increases plasma insulin and amylin. Am. J. Physiol. Endocrinol. Metab. Jul 2005; 289(1): E40-E45.
Amylin (8-37) selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle. Amylin (8-37) is a truncated peptide of native rat smylin. Amylin (8-37) increases whole-body and muscle insulin sensitivity and consistently reduces basal insulin levels in normal and hGH-induced insulin-resistant rats. Amylin (8-37) also elicits a significant alteration of in-vivo lipid metabolism.
Solubility
The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents.
Formula
C135H210N40O45
M.W.
3113.4
Purity
> 95%
Storage
Before use, store the peptide in the DRY form at 0°C - 5°C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions.
* For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.